Charles Schwab Investment Management Inc Pmv Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.51 - $2.21 $131,871 - $193,003	-87,332 Reduced 32.84%	178,592 $289,000
Q1 2024 May 08, 2024	BUY	$1.51 - $3.12 $11,169 - $23,078	7,397 Added 2.86%	265,924 $452,000
Q4 2023 Feb 06, 2024	SELL	$1.23 - $6.6 $13,616 - $73,062	-11,070 Reduced 4.11%	258,527 $801,000
Q3 2023 Nov 08, 2023	BUY	$6.01 - $8.93 $58,627 - $87,112	9,755 Added 3.75%	269,597 $1.66 Million
Q2 2023 Aug 09, 2023	BUY	$3.94 - $6.27 $25,089 - $39,927	6,368 Added 2.51%	259,842 $1.63 Million
Q1 2023 May 11, 2023	BUY	$4.77 - $9.16 $7,226 - $13,877	1,515 Added 0.6%	253,474 $1.21 Million
Q4 2022 Feb 13, 2023	BUY	$8.17 - $12.95 $28,456 - $45,104	3,483 Added 1.4%	251,959 $2.19 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $405,600 - $611,247	35,579 Added 16.71%	248,476 $2.96 Million
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $166,333 - $404,211	18,021 Added 9.25%	212,897 $3.03 Million
Q1 2022 May 13, 2022	BUY	$14.86 - $23.55 $75,741 - $120,034	5,097 Added 2.69%	194,876 $4.06 Million
Q4 2021 Feb 11, 2022	BUY	$19.99 - $30.24 $52,293 - $79,107	2,616 Added 1.4%	189,779 $4.38 Million
Q3 2021 Nov 16, 2021	BUY	$26.84 - $36.58 $1.96 Million - $2.67 Million	72,875 Added 63.76%	187,163 $5.58 Million
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $817,976 - $1.05 Million	29,203 Added 34.32%	114,288 $3.91 Million
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $58,897 - $95,089	1,921 Added 2.31%	85,085 $2.8 Million
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $2.65 Million - $5.12 Million	83,164 New	83,164 $5.12 Million

43.2M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $63.4M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.